Immunome

IMNM55

High Growth

$10.96arrow_drop_up11.40%$1.11

High Growth

IMNM55

$10.96

arrow_drop_up11.40%$1.11

High Growth

Performance History

Key Stats
Open	$9.82
Prev. Close	$9.82
EPS	-7.94
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	9.82	9.82
52 Week Range	6.93	30.95

Ratios







EPS	-7.94

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Immunome (IMNM)

Immunome Inc (IMNM) is a biopharmaceutical company that focuses on developing and commercializing innovative immunotherapies for the treatment of cancer and other diseases. With a mission to harness the power of the immune system, Immunome is at the forefront of cutting-edge research and technology in the field of immuno-oncology. Through its proprietary discovery engine, Immunome has developed a robust pipeline of novel therapeutic candidates that have the potential to revolutionize the way cancer is treated.

One of the key factors driving the success of Immunome Inc is its smart analysis methodology. By leveraging advanced computational algorithms and artificial intelligence, Immunome is able to analyze vast amounts of genomic data to identify promising targets for immunotherapy. This data-driven approach allows Immunome to quickly and efficiently identify new drug candidates, reducing the time and cost associated with traditional drug discovery methods. With its smart analysis capabilities, Immunome has a unique competitive advantage in the highly competitive biopharmaceutical industry.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Purnanand Duddu Sarma Ph.D.
Headquarters: Exton
Employees: 37
Exchange: NASDAQ

Keep an eye on Immunome

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Immunome 's (IMNM) price per share?

The current price per share for Immunome (IMNM) is $10.96. The stock has seen a price change of $1.12 recently, indicating a 11.41% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Immunome (IMNM)?

For Immunome (IMNM), the 52-week high is $30.96, which is 182.36% from the current price. The 52-week low is $6.93, the current price is 58.21% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Immunome (IMNM) a growth stock?

Immunome (IMNM) has shown an average price growth of -3.36% over the past three years. It has received a score of 71 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Immunome as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Immunome (IMNM) stock price performance year to date (YTD)?

As of the latest data, Immunome (IMNM) has a year-to-date price change of -0.42%. Over the past month, the stock has experienced a price change of -8.71%. Over the last three months, the change has been -30.21%. Over the past six months, the figure is -22.9%.

help

Is Immunome (IMNM) a profitable company?

Immunome (IMNM) has a net income of -$106.81M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.51K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $14.02M, although specific revenue growth data is currently not available. Operating income is noted at -$109.53M. Furthermore, the EBITDA is $52.8M.

help

What is the market capitalization of Immunome (IMNM)?

Immunome (IMNM) has a market capitalization of $677.85M. The average daily trading volume is 10.94, indicating the stock's liquidity and investor engagement.